Literature DB >> 2711758

Awareness and treatment of hypercholesterolemia: results of the first survey of the MONICA Project Augsburg.

A Döring1, B Filipiak, G Winkler, U Keil.   

Abstract

In the first survey of the MONICA project Augsburg (1984/1985), awareness and treatment of hypercholesterolemia was determined on a two-stage cluster sample of 5069 25-64 year old citizens (participation 79.6%). Hypercholesterolemia was defined according to the Conference of the European Atherosclerosis Society (EAS) and of the National Cholesterol Education Program (NCEP). Awareness (elevated lipid levels found during the last 12 months), and drug and dietary treatment were determined by an interview. The awareness was low and varied between 4 and 24% in the different age-sex groups with no significant differences between sexes, with one exception: The awareness in women aged 55-64 years with cholesterol levels greater than or equal to 300 mg/dl was 38% and differed significantly from that found in men in the same age group (21%). Older participants showed a higher degree of awareness than younger; in men the awareness was independent from the cholesterol level, in women those with higher levels showed a better awareness than those with lower levels (results from a logistic regression analysis for cholesterol levels greater than or equal to 240 mg/dl). The use of lipid-lowering drugs was low in the study population (2% in men, 1% in women). The drug treatment of hypercholesterolemia was low and in no age-sex group higher than 7%, despite the definition of hypercholesterolemia; the dietary treatment was not higher than 20%. In conclusion it is shown, that there is a great need for the identification and management of hypercholesterolemia in the examined population in Southern Germany.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2711758     DOI: 10.1007/BF02084745

Source DB:  PubMed          Journal:  Soz Praventivmed        ISSN: 0303-8408


  7 in total

1.  The Lipid Research Clinics Coronary Primary Prevention Trial results. II. The relationship of reduction in incidence of coronary heart disease to cholesterol lowering.

Authors: 
Journal:  JAMA       Date:  1984-01-20       Impact factor: 56.272

2.  [Prevalence, awareness and degree of treatment of hypertension in an urban population. Results of the Munich Blood Pressure Study I].

Authors:  J Stieber; A Döring; U Keil
Journal:  MMW Munch Med Wochenschr       Date:  1982-09-03

3.  Health implications of obesity. National Institutes of Health Consensus Development Conference. 11-13 February 1985.

Authors: 
Journal:  Ann Intern Med       Date:  1985-12       Impact factor: 25.391

4.  The cardiovascular risk factor profile in the study area Augsburg. Results from the first MONICA survey 1984/85.

Authors:  U Keil; J Stieber; A Döring; L Chambless; U Härtel; B Filipiak; H W Hense; M Tietze; J G Gostomzyk
Journal:  Acta Med Scand Suppl       Date:  1988

5.  Strategies for the prevention of coronary heart disease: a policy statement of the European Atherosclerosis Society.

Authors: 
Journal:  Eur Heart J       Date:  1987-01       Impact factor: 29.983

6.  The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart disease.

Authors: 
Journal:  JAMA       Date:  1984-01-20       Impact factor: 56.272

7.  Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. The Expert Panel.

Authors: 
Journal:  Arch Intern Med       Date:  1988-01
  7 in total
  2 in total

1.  Comparison of risk factors for coronary heart disease in Dresden and Münster. Results of the DRECAN (Dresden Cardiovascular Risk and Nutrition) study and the PROCAM (Prospective Cardiovascular Münster) Study.

Authors:  W Jaross; G Assmann; S Bergmann; H Schulte
Journal:  Eur J Epidemiol       Date:  1994-06       Impact factor: 8.082

2.  Cardiovascular risk factors, ECG abnormalities and quality of life in subjects with atrial fibrillation.

Authors:  J Gehring; S Perz; J Stieber; R Küfner; U Keil
Journal:  Soz Praventivmed       Date:  1996
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.